欧洲视网膜专家学会(EURETINA)成立于1999年,由对治疗黄斑以及玻璃体视网膜疾病感兴趣的临床医生、科学家和研究者组成。EURETINA的宗旨是促进欧洲玻璃体视网膜和黄斑专家之间的知识交流并建立个人联系;支持和促进欧洲在玻璃体视网膜和黄斑方面的研究;将相关专业知识传播给普通眼科医师;与欧洲之外的类似相关团体保持联系。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)
Submission closes on Tuesday 1st March 23:59 CET.
Dear Colleagues,
It is my great honour to invite you to the 22nd Euretina Congress in Hamburg, Germany from Thursday 1st to Sunday 4th September 2022. The meeting will take place at the recently renovated, state-of-the-art Congress Centre Hamburg (CCH), which is ideally located close to the bustling centre of Hamburg.
While the scientific content will be streamed to facilitate virtual participation for those who need it, we strongly encourage you to join us face-to-face, along with our speakers, as we reunite for the first time after the isolation and disruption of the last two years.
The programme in Hamburg will span four days and boast a cutting-edge scientific programme. Selected content has been submitted by our own Society members and reviewed by experts on our eight new Subspecialty Section Committees.
This year’s Congress will also see a much-awaited return to our in-person exhibition, and we are grateful to our industry partners for their commitment and enthusiasm to return on-site. We will also host surgical skills training courses and live poster presentations for the benefit of face-to-face delegates. There will be an increased focus on networking and social events this year, which will be tailored to both members and delegates, in a bid to make up for the missed opportunities since our last face-to-face Congress in Paris 2019.
Early registration will open in April for both face-to-face and virtual delegates, while programme information will be updated as it is finalised, so do keep an eye on the Euretina website for news and developments.
On behalf of the Executive and Board I look very forward to welcoming you back to meet again at this year’s Euretina Congress in its full glory!
With very best wishes,
Prices are in Euro & listed without VAT.
◆ 参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。